Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man

Perceived exertion as an indicator of somatic stress

Borg, G. (1970) · Journal of Rehabilitation Medicine · doi:10.2340/1650197719702239298 · Cited by 4,723

A Flexible System of Enzymatic Analysis

Lowry, O. H., & Passonneau, J. V. (1972) · Elsevier eBooks · doi:10.1016/b978-0-12-457950-7.x5001-3 · Cited by 4,050

A Nomogram for Calculation of Aerobic Capacity (Physical Fitness) From Pulse Rate During Submaximal Work

Åstrand, P. O., & Ryhming, I. (1954) · Journal of Applied Physiology · doi:10.1152/jappl.1954.7.2.218 · Cited by 1,558

Neuropeptide Y: complete amino acid sequence of the brain peptide.

Tatemoto, K. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5485 · Cited by 1,378

Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function

Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., Martling, C., Tatemoto, K., Mutt, V., Polak, J. M., Bloom, S. R., & Goldstein, M. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07171.x · Cited by 1,199

Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers

Ekblad, E., Edvinsson, L. I., Wahlestedt, C., Uddman, R., Håkanson, R., & Sundler, F. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90064-8 · Cited by 741

High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man

Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., & Goldstein, M. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90401-9 · Cited by 616

Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic method

Hjemdahl, P., Daleskog, M., & Kahan, T. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90384-9 · Cited by 564

Coexistence of peptides and classical neurotransmitters

Lundberg, J. M., & Hökfelt, T. G. M. (1983) · Trends in Neurosciences · doi:10.1016/0166-2236(83)90149-2 · Cited by 560

Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α‐adrenoceptor blockade

Lundberg, J. M., & Tatemoto, K. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07157.x · Cited by 534

Neurohormonal Activation in Heart Failure After Acute Myocardial Infarction Treated with Beta-Receptor Antagonists

Persson, H., Andréasson, K., Kahan, T., Eriksson, S. V., Tidgren, B., Hjemdahl, P., Hall, C., & Erhardt, L. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00196-9 · Cited by 27

Co-existence and co-function

Gibbins, I. L. (1989) · Springer eBooks · doi:10.1007/978-94-009-0835-2_13 · Cited by 27

Neuropeptide Y1receptor vasoconstriction in exercising canine skeletal muscles

Buckwalter, J. B., Hamann, J. J., & Clifford, P. S. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00427.2005 · Cited by 26

Sympathetic Neural Control in Humans with Anxiety‐Related Disorders

Bigalke, J. A., & Carter, J. R. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210027 · Cited by 29

Neuropeptide Y in the primate model of subarachnoid hemorrhage

Pluta, R. M., Deka-Starosta, A., Zauner, A., Morgan, J. K., Muraszko, K. M., & Oldfield, E. H. (1992) · Journal of neurosurgery · doi:10.3171/jns.1992.77.3.0417 · Cited by 25

Increased immunoreactive neuropeptide Y in platelets of spontaneously hypertensive rats (SHR)

Ogawa, T., Kitamura, K., Kawamoto, M., Eto, T., & Tanaka, K. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92759-9 · Cited by 25

Cigarette smoke‐induced elevation of plasma neuropeptide Y levels in man

Rudehill, A., Franco‐Cereceda, A., Hemsén, A., Stensdotter, M., Pernow, J., & Lundberg, J. M. (1989) · Clinical Physiology · doi:10.1111/j.1475-097x.1989.tb00976.x · Cited by 24

Sinus and atrioventricular nodal distribution of sympathetic fibers that contain neuropeptide Y.

Warner, M. R., & Levy, M. N. (1990) · Circulation Research · doi:10.1161/01.res.67.3.713 · Cited by 23

C‐peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin‐dependent diabetic patients

JOHANSSON, & Pernow, J. (1999) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1999.00475.x · Cited by 23

Neuropeptide Y signalling on hippocampal stem cells in health and disease

Gray, W. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.02.021 · Cited by 21

Splanchnic release of neuropeptide Y during prolonged exercise with and without β‐adrenoceptor blockade in healthy man

AHLBORG, G., & Lundberg, J. M. (1991) · Clinical Physiology · doi:10.1111/j.1475-097x.1991.tb00663.x · Cited by 21

The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects

Hetland, M. L., Eldrup, E., Bratholm, P. S., & Christensen, N. J. (1991) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519109091608 · Cited by 21

Neuropeptide Y modifies the hypertrophic response of adult ventricular cardiomyocytes to norepinephrine

Kanevskij, M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00517-x · Cited by 21

Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans

AHLBORG, G., Weitzberg, E., & Lundberg, J. M. (1992) · Clinical Physiology · doi:10.1111/j.1475-097x.1992.tb00301.x · Cited by 21

Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction

Sundkvist, G., Bramnert, M., Bergström, B., Manhem, P., Lilja, B., & Ahrén, B. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90028-p · Cited by 21

Neuropeptide Y in Sympathetic Co‐Transmission: Recent Advances in the Search for Neuropeptide Y Antagonists

Edvinsson, L. I., Erlinge, D., Sun, X. Y., & Hedner, T. (1994) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1994.tb01098.x · Cited by 21

Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure

Feng, Q., LAMBERT, M., Callow, I. D., & ARNOLD, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104610 · Cited by 20

Role of NPY for vasoregulation in the splanchnic circulation during portal hypertension

Wiest, R., Jurzik, L., Herold, T., Straub, R. H., & Schölmerich, J. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.044 · Cited by 19

Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene‐related peptide responses to mental stress and adrenaline in humans

Tidgren, B., Theodorsson, E., & Hjemdahl, P. (1991) · Clinical Physiology · doi:10.1111/j.1475-097x.1991.tb00649.x · Cited by 19

Plasma concentration of neuropeptide Y in patients with adrenal hypertension

Tabarin, A., Minnot, A. P., Dallochio, M., Roger, P., & Ducassou, D. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90023-n · Cited by 19

Sympathetic response during cardiopulmonary bypass

Sun, L. S., Adams, D. C., Delphin, E., Graham, J., Meltzer, E., Rose, E. A., & Heyer, E. J. (1997) · Critical Care Medicine · doi:10.1097/00003246-199712000-00015 · Cited by 19

Renal sympathetic nerve activation in relation to reserpine‐induced depletion of neuropeptide Y in the kidney of the rat

Pernow, J., Thorén, P., Millberg, B. I., & Lundberg, J. M. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08458.x · Cited by 19

Prevention of unfavourable effects of cigarette smoke on flap viability using botulinum toxin in random pattern flaps: An experimental study

Karayel, H., Kaya, B., Çaydere, M., Terzioğlu, A., & Aslan, G. (2015) · Plastic Surgery · doi:10.1177/229255031502300309 · Cited by 18

Decreased Myocardial Chromogranin A Expression and Colocalization With Brain Natriuretic Peptide During Reverse Cardiac Remodeling After Ventricular Unloading

Wohlschlaeger, J., von Winterfeld, M., Milting, H., Banayosy, A. E., Schmitz, K. J., Takeda, A., Takeda, N., Azhari, P., Schmid, Ç., August, C., et al. (2008) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2008.01.017 · Cited by 18

PP, PYY and NPY: Synthesis, Storage, Release and Degradation

von Hörsten, S., Hoffmann, T., Alfalah, M., Wrann, C. D., Karl, T., Pabst, R., & Bedoui, S. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18764-3_2 · Cited by 18

Psychopharmacological possibilities in the acute disaster setting

Simon, A. B., & Gorman, J. M. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.03.004 · Cited by 18

Post‐exercise depression of baroreflex slowing of the heart in humans

Ulman, L. G., Potter, E. K., McCloskey, D. I., & Morris, M. J. (1997) · Clinical Physiology · doi:10.1111/j.1365-2281.1997.tb00009.x · Cited by 18

Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension

Wiest, R., Jurzik, L., Moleda, L., Froh, M., Schnabl, B., von Hörsten, S., Schölmerich, J., & Straub, R. H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.08.023 · Cited by 17

Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure

Ullman, B., Lindvall, K., Lundberg, J. M., Sigurðsson, A. F., & Swedberg, K. B. (1994) · Clinical Physiology · doi:10.1111/j.1475-097x.1994.tb00498.x · Cited by 17

NPY and extreme stress: lessons learned from posttraumatic stress disorder

Dutton, M. A., Lee, E. W., & Żukowska, Z. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7417-9_16 · Cited by 18

Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction

Ullman, B., Pernow, J., Lundberg, J. M., Åström, H., & Bergfeldt, L. (2002) · Clinical Science · doi:10.1042/cs1030535 · Cited by 17

Repeated renal and splenic sympathetic nerve stimulation in anaesthetized pigs: maintained overflow of neuropeptide Y in controls but not after reserpine

Modin, A., Pernow, J., & Lundberg, J. M. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90132-5 · Cited by 17

Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises

Eugster, P. J., Bourdillon, N., Vocat, C., Wuerzner, G., Nguyen, T. D., Millet, G. P., & Grouzmann, E. (2022) · Neuropeptides · doi:10.1016/j.npep.2022.102232 · Cited by 16

Roles of nuclear NPY and NPY receptors in the regulation of the endocardial endothelium and heart functionThis paper is one of a selection of papers published in this Special issue, entitled Second Messengers and Phosphoproteins—12th International Conference.

Jacques, D., Sader, S., Perreault, C., Abdel-Samad, D., & Provost, C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y05-162 · Cited by 16

Plasma immunoreactive Neuropeptide Y in congestive heart failure at rest and during exercise

Madsen, B. K., Husum, D., Videbæk, R., Stokholm, K. H., Sælsen, L., & Christensen, N. J. (1993) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519309092555 · Cited by 16

Plasma neuropeptide Y levels in the acute and early convalescent phase after myocardial infarction

Omland, T., Opstad, P. K., & Dickstein, K. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90543-6 · Cited by 16

Age‐related changes of exercise‐induced plasma catecholamines and neuropeptide Y responses in normal human subjects

Jensen, E. W., Espersen, K., Kanstrup, I., & CHRISTENSEN, N. J. (1992) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1992.tb09277.x · Cited by 16

Prejunctional Effects of Neuropeptide Y and Its Role as a Cotransmitter

Westfall, T. C. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18764-3_6 · Cited by 15

Placental Neuropeptide Y ( NPY ) and NPY receptors expressions and serum NPY levels in preeclampsia

Klinjampa, R., Sitticharoon, C., Souvannavong-Vilivong, X., Sripong, C., Keadkraichaiwat, I., Churintaraphan, M., Chatree, S., & Lertbunnaphong, T. (2019) · Experimental Biology and Medicine · doi:10.1177/1535370219831437 · Cited by 15

Influence of Endogenous Neuropeptide Y (NPY) on the Sympathetic-Parasympathetic Interaction in the Canine Heart

Ilebekk, A., Björkman, J., & Nordlander, M. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000177986.21929.d8 · Cited by 15

Circulating noradrenaline leads to release of neuropeptide Y from cardiac sympathetic nerve terminals via activation of β‐adrenergic receptors

van Weperen, V. Y. H., Hoang, J. D., Jani, N. R., Khaky, A., Herring, N., Smith, C. B., & Vaseghi, M. (2024) · The Journal of Physiology · doi:10.1113/jp285945 · Cited by 14

Treadmill exercise-induced stress causes a rise of blood histamine in normotensive but not in primary hypertensive humans

Campos, H. A., Montenegro, M., Velasco, M., Romero, E., Alvarez, R. P., & Urbina‐Quintana, A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00598-1 · Cited by 14

Neuropeptide y in sympathetic nerves — evidence for Y1 receptor mediated vascular control

Malmström, R. E., & Lundberg, J. M. (1997) · Elsevier eBooks · doi:10.1016/b978-012304990-2/50004-4 · Cited by 14

Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation.

Miller, M. A., Sagnella, G. A., Markandu, N. D., & MacGregor, G. A. (1990) · Clinica Chimica Acta · doi:10.1016/0009-8981(90)90270-3 · Cited by 14

Circulating neuropeptide Y in plasma from uremic patients consists of multiple peptide fragments

Hegbrant, J., Thysell, H., & Ekman, R. (1995) · Peptides · doi:10.1016/0196-9781(94)00206-l · Cited by 14

Neuropeptide-Y and Atrial Natriuretic Peptide as Prognostic Markers in Patients on Hemodialysis

Odar‐Cederlöf, I., ERICSSON, F., Theodorsson, E., & Kjellstrand, C. M. (2003) · ASAIO Journal · doi:10.1097/00002480-200301000-00012 · Cited by 13

Demonstration of Neuropeptide Y and Its Precursor in Plasma and Follicular Fluid*

Jørgensen, J. C., O'Hare, M. M. T., & Andersen, C. Y. (1990) · Endocrinology · doi:10.1210/endo-127-4-1682 · Cited by 13

Spectral analysis of blood pressure and heart rate, catecholamine and neuropeptide Y plasma levels in a new model of neurogenic orthostatic hypotension in dog

Verwaerde, P., Sénard, J., Mazerolles, M., Tran, M. A., Damase‐Michel, C., Montastruc, J., & Montastruc, P. (1996) · Clinical Autonomic Research · doi:10.1007/bf02291227 · Cited by 12

Inhibitory effects of neuropeptide Y on splanchnic glycogenosis and renin release in humans

AHLBORG, G., & Lundberg, J. M. (1994) · Clinical Physiology · doi:10.1111/j.1475-097x.1994.tb00505.x · Cited by 12

Peripheral Autonomic Pathways

Gibbins, I. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374236-0.10005-7 · Cited by 12

Neuropeptide Y in the noradrenergic neurons induces the development of cardiometabolic diseases in a transgenic mouse model

Savontaus, E., Ruohonen, S. T., & Pesonen, U. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.105574 · Cited by 11

Post-exercise Nasal Vasoconstriction and Hyporeactivity: Possible Involvement of Neuropeptide Y

Lacroix, J. S., Correia, F. D. O., Fathi, M., & Grouzmann, E. (1997) · Acta Oto-Laryngologica · doi:10.3109/00016489709113446 · Cited by 11

α-Trinositol: A Functional (Non-receptor) Neuropeptide Y Antagonist in Vasculature

Sun, X., You, J., Hedner, T., Erlinge, D., Fellström, B., Yoo, H., Wahlestedt, C., & Edvinsson, L. I. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05882.x · Cited by 11

Plasma neuropeptide Y and catecholamines in pediatric patients undergoing cardiac operations

Sun, L. S., Du, F., Schechter, W. S., Quaegebeur, J. M., & Vulliemoz, Y. (1997) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(97)70324-6 · Cited by 11

Effects of Neuropeptide Y on Cardiac Performance and Renal Blood Flow in Conscious Normotensive and Renal Hypertensive Rabbits

Minson, R. B., McRitchie, R. J., Morris, M. J., & Chalmers, J. P. (1990) · Clinical and Experimental Hypertension · doi:10.3109/10641969009074733 · Cited by 11

Inhibition of vagal vasodilatation by a selective neuropeptide Y Y2 receptor agonist in the bronchial circulation of anaesthetised dogs

Mahns, D. A., Lacroix, J. S., & Potter, E. K. (1998) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(98)00086-1 · Cited by 11

Vasoactive peptides in Bartter's syndrome

Stahl, M. M. S., Vaara, I., Hedner, P., & Ekman, R. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00744.x · Cited by 11

Peripheral Autonomic Pathways

Gibbins, I. L. (2004) · Elsevier eBooks · doi:10.1016/b978-012547626-3/50007-7 · Cited by 10

Radioimmunoassay of neuropeptide Y (NPY) in biological fluids. Circulating NPY levels depend on renal function

Stridsberg, M., & Lundqvist, G. (1989) · Clinica Chimica Acta · doi:10.1016/0009-8981(89)90131-9 · Cited by 10

Saxagliptin: A potential doping agent? A randomized, double‐blinded, placebo‐controlled, and crossover pilot study in young active men

Bourdillon, N., Eugster, P. J., Vocat, C., Nguyen, T. D., Wuerzner, G., Grouzmann, E., & Millet, G. P. (2022) · Physiological Reports · doi:10.14814/phy2.15515 · Cited by 9

Effects of intense antecedent sympathetic stimulation on sympathetic neurotransmission in the heart.

Yang, T., & Levy, M. N. (1993) · Circulation Research · doi:10.1161/01.res.72.1.137 · Cited by 9

Sympathetic Nervous System Responses to Psychosocial Stressors

Mills, P. J., & Dimsdale, J. E. (1992) · Springer eBooks · doi:10.1007/978-1-4899-0697-7_2 · Cited by 9

Is neuropeptide Y co-released with catecholamines in experimental arterial hypertension following sinoaortic denervation?

Tavernier, G., Damase‐Michel, C., Portolan, G., Tran, M. A., & Montastruc, J. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00176621 · Cited by 9

The Ratio of Low-Frequency to High-Frequency in Ambulatory Electrocardiographic Monitoring Immediately Before Coronary Angiography as a Predictor of the Presence of Coronary Artery Disease

Miyase, Y. (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1661w · Cited by 8

The influence of physical exercise on alterations in concentrations of neuropeptide Y, leptin and other selected hormonal and metabolic parameters in sportspeople

Zajadacz, B., Skarpańska-Stejnborn, A., Brzenczek‐Owczarzak, W., Juszkiewicz, A., Naczk, M., & Adach, Z. (2009) · Biology of Sport · doi:10.5604/20831862.901136 · Cited by 8

Neuropeptide Y release and contractile properties: differences between canine veins and arteries

Hunter, L. W., Tyce, G. M., & Rorie, D. K. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00475-x · Cited by 8

Moderated mediation for exercise maintenance in pain and posttraumatic stress disorder: A randomized trial.

Scioli, E. R., Smith, B. N., Whitworth, J. W., Spiro, A., Esterman, M. S., Dutra, S. J., Bogdan, K. M., Eld, A., & Rasmusson, A. M. (2020) · Health Psychology · doi:10.1037/hea0000876 · Cited by 8

Maturation of Rat Renal Tubular Response to α-Adrenergic Agonists and Neuropeptide Y: A Study on the Regulation of Na+,K+-ATPase

Ohtomo, Y., Ono, S., SAHLGREN, B., & Aperia, A. C. (1996) · Pediatric Research · doi:10.1203/00006450-199603000-00024 · Cited by 7

Footshock-induced rise of rat blood histamine depends upon the activation of postganglionic sympathetic neurons

Campos, H. A., & Montenegro, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00097-1 · Cited by 7

Beta-adrenoceptor stimulation increases neuropeptide Y release from sympathetic nerves in intact rats

Evéquoz, D., Grouzmann, E., Nussberger, J., Niederberger, M., Brunner, H. R., & Waeber, B. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00065-j · Cited by 7

Effect of oral administration of nifedipine on neuropeptide Y‐ and noradrenaline‐induced vasoconstriction in the human forearm

Pernow, J., Lundberg, J. M., & Kaijser, L. (1989) · Clinical Physiology · doi:10.1111/j.1475-097x.1989.tb00957.x · Cited by 7

Neuropeptide Y and Cardiovascular Function

Morris, M. J. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18764-3_11 · Cited by 7

Stronger correlation with myocardial ischemia of high-sensitivity troponin T than other biomarkers

Pipikos, T., Kapelouzou, A., Tsilimigras, D. I., Fostinis, Y. P., Pipikou, M., Theodorakos, A., Pavlidis, A. N., Kontogiannis, C., Cokkinos, D. V., & Koutelou, M. (2018) · Journal of Nuclear Cardiology · doi:10.1007/s12350-018-1199-6 · Cited by 6

Endogenous dipeptidyl peptidase IV modulates skeletal muscle arteriolar diameter in rats

Neidert, L. E., Tarhuni, M. A., Goldman, D., Kluess, H. A., & Jackson, D. N. (2018) · Physiological Reports · doi:10.14814/phy2.13564 · Cited by 6

The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure

Zhang, W., Lundberg, J. M., & Thorén, P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00435-x · Cited by 6

Effect of baroreceptor activation and systemic hypotension on plasma endothelin 1 and neuropeptide Y

Notarius, C. F., Erice, F., Stewart, D. J., & Magder, S. A. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-162 · Cited by 6

Circulating neuropeptide Y in dog plasma consists of multiple peptide fragments

Senanayake, P. D., Warner, M. R., Brosnihan, K. B., Levy, M. N., & Ferrario, C. M. (1992) · Peptides · doi:10.1016/0196-9781(92)90024-w · Cited by 6

α2-Adrenoceptor modulation of catecholamine and neuropeptide Y responses during haemorrhagic hypotension in anaesthetized dogs

Briand, R., Yamaguchi, N., Gagné, J., Nadeau, R. A., & de Champlain, J. (1990) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(90)90134-5 · Cited by 6

Lack of Relationship Between Sympathetic Nervous System Activity, Measured by Two Circulating Markers, and Blood Pressure in Diabetic and Nondiabetic Subjects

Carstensen, E., Sampson, M., Savage, M. W., Ware, M., Williams, G., & Yudkin, J. S. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00079-2 · Cited by 5

Segmental vitiligo: A distinct entity with unique pathogenesis and clinical implications

Shen, N., Fang, Q., Xuan, Y., Liu, Y., Xiang, L. F., Passeron, T., & Zhang, C. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.12.009 · Cited by 4

Functional sympatholysis of neuropeptide Y‐mediated vasoconstriction in humans

Wakeham, D. J., Hissen, S. L., MacNamara, J. P., Davis, S. L., Fadel, P. J., Levine, B. D., & Hearon, C. M. (2025) · The Journal of Physiology · doi:10.1113/jp288412 · Cited by 4

Plasma Neuropeptide Y During Dynamic Exercise in Patients with Essential Hypertension

Pruszczyk, P., & Chlebus, M. (1995) · Clinical and Experimental Hypertension · doi:10.3109/10641969509033634 · Cited by 4

Neurohumoral Changes in Patients With Left Ventricular Dysfunction Following Acute Myocardial Infarction and the Effect of Nitrate Therapy: A Randomized, Double-Blind, Placebo-Controlled Long-Term Study

Tingberg, E., Roijer, A., Thilén, U., & Öhlin, H. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000246149.92535.59 · Cited by 4

Cholinergic stimulation of neuropeptide Y secretion from the isolated perfused rat stomach

McIntosh, C. H. S., Dadgar, A., & Kwok, Y. N. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90010-r · Cited by 4

Phentolamine‐ and clonidine‐induced changes in plasma neuropeptide Y‐like immunoreactivity during sympathetic activation in man

Pernow, J., Lundberg, J. M., & Kaijser, L. (1987) · Clinical Physiology · doi:10.1111/j.1475-097x.1987.tb00185.x · Cited by 4

Neurological Mechanisms Exploration and Therapeutic Targets in Segmental Vitiligo Accompanied by White Hair

Fu, S., Xie, B., & Song, X. (2025) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.70020 · Cited by 3

Neuropeptide Y drives ventricular arrhythmogenesis in chronic ischemic heart failure via calcium mishandling

Koya, J., Temma, T., Kawakami, K., Karube, F., Tanei, Z., Kawasaki, M., Shimano, K., Saito, S., Tatsuta, D., Nishino, K., et al. (2025) · Heart Rhythm · doi:10.1016/j.hrthm.2025.08.011 · Cited by 3

Ventricular Fibrillation Induced by Ischemia-Reperfusion Is Not Prevented by the NPY Y2 Receptor Antagonist BIIE0246

Ilebekk, A., Eriksen, M., Sevre, K., Aspelin, T., Björkman, J., Lyberg, T., & Nordlander, M. (2006) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248406292709 · Cited by 3

Neuropeptide Y levels in central and peripheral cerebrospinal fluid in patients with intracranial disorders

von Holst, H., Rudehill, A., & Lundberg, J. M. (1991) · Acta Neurochirurgica · doi:10.1007/bf01405141 · Cited by 2

PLASMA NEUROPEPTIDE Y AND ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN MAN

Russell, A. E., Aylward, P. E., Smith, S. A., Cain, M. D., McRitchie, R. J., & Chalmers, J. P. (1988) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1988.tb01041.x · Cited by 2

Atrial Fibrillation after Coronary Artery Bypass Surgery : A Study of Causes and Risk Factors

Jidéus, L. (2001) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2

Cardiovascular trophic effects from the sympathetic nerve cotransmitter neuropeptide Y in end-stage renal disease?

Esler, M., & Hastings, J. (2003) · Journal of Hypertension · doi:10.1097/00004872-200307000-00011 · Cited by 2

Noradrenaline and Neuropeptide Y in the Sympathetic System: Prejunctional Interactions and Regulation of Release

Dahlöf, P., & Dahlöf, C. G. H. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-232350-8.50011-x · Cited by 2

Metabolic override: Adding neuropeptide Y to the list of vasoconstrictors attenuated by exercise

Bommarito, J. C., & Millar, P. J. (2025) · The Journal of Physiology · doi:10.1113/jp289205 · Cited by 1

Long-duration head-down bed rest alters human sympathetic neurocirculatory regulation

Iannarelli, N. J., Spafford, J. E., Greaves, D. K., Denise, P., Normand, H., Hughson, R. L., Klassen, S. A., & Shoemaker, J. K. (2025) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00309.2025 · Cited by 1

Synthesis of the Cardiac Purkinje-fiber Action Potential Using a Computer Model

Zaza, A., & Rosen, M. R. (2000) · CRC Press eBooks · doi:10.3109/9780203303887-11 · Cited by 1

NPY and Hippocampal Neurogenesis

Gray, W., & Scharfman, H. E. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7427-6_13 · Cited by 1

Immunoregulation by Neuropeptides Other than Corticotropin and Melanotropin

Harbour, D. V. (1994) · Springer eBooks · doi:10.1007/978-3-642-78480-4_5 · Cited by 1

Interactions between Neuropeptide Y and Noradrenaline Receptor Mechanisms in Sympathetic Vascular Control

Lundberg, J. M., Pernow, J., Franco‐Cereceda, A., & Rudehill, A. (1987) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-08949-9_26 · Cited by 1

Is neuropeptide Y really involved with regulating resting blood pressure?

Kluess, H. A. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00791.2024 · Cited by 1

Co-release of neuropeptide Y and catecholamines during physical exercise in man

Lundberg, J. M., Martinsson, A., Hemsén, A., Theodorsson, E., Svedenhag, J., Ekblom, B. T., & Hjemdahl, P. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91837-6 · Cited by 223

Increases in plasma neuropeptide Y concentrations during sympathetic activation in man

Morris, M. J., Russell, A. E., Kapoor, V., Cain, M. D., Elliott, J. M., West, M. J., Wing, L. M. H., & Chalmers, J. P. (1986) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(86)90089-5 · Cited by 159

PLASMA NEUROPEPTIDE Y LEVELS RISE IN PATIENTS UNDERGOING EXERCISE TESTS FOR THE INVESTIGATION OF CHEST PAIN

Morris, M. J., Elliott, J. M., Cain, M. D., Kapoor, V., West, M., & Chalmers, J. P. (1986) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1986.tb00923.x · Cited by 39

Splanchnic release of neuropeptide Y during prolonged exercise with and without β‐adrenoceptor blockade in healthy man

AHLBORG, G., & Lundberg, J. M. (1991) · Clinical Physiology · doi:10.1111/j.1475-097x.1991.tb00663.x · Cited by 21

Kinetics of neuropeptide Y, catecholamines, and physiological responses during moderate and heavy intensity exercises

Eugster, P. J., Bourdillon, N., Vocat, C., Wuerzner, G., Nguyen, T. D., Millet, G. P., & Grouzmann, E. (2022) · Neuropeptides · doi:10.1016/j.npep.2022.102232 · Cited by 16